Compare LSBK & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LSBK | INO |
|---|---|---|
| Founded | 1891 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.8M | 136.6M |
| IPO Year | 2006 | 1998 |
| Metric | LSBK | INO |
|---|---|---|
| Price | $14.94 | $2.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 17.4K | ★ 1.0M |
| Earning Date | 01-23-2026 | 11-10-2025 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 105.28 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $27,774,000.00 | $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $21,219.94 |
| P/E Ratio | $12.44 | ★ N/A |
| Revenue Growth | ★ 9.61 | N/A |
| 52 Week Low | $11.50 | $1.30 |
| 52 Week High | $16.95 | $4.08 |
| Indicator | LSBK | INO |
|---|---|---|
| Relative Strength Index (RSI) | 67.56 | 49.53 |
| Support Level | $14.75 | $1.86 |
| Resistance Level | $15.10 | $2.27 |
| Average True Range (ATR) | 0.24 | 0.12 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 89.73 | 59.72 |
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.